Verizon Communications Inc. (0Q1S)
London Stock Exchange · UK · prices in USD · close of 28 Oct 2026
Key indicators
| Last close | USD 43.25 |
|---|---|
| 52-week range | 35.00 – 51.80 |
| Return, 1 month / 3 months | −7.1% / −10.5% |
| Return, 1 year / 3 years | +11.9% / +48.6% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 36.6% |
| Worst drawdown (1 year) | -22.1% |
| Average daily value traded | 3.03M USD |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Verizon Communications is a telecommunications company based in the United States. It provides wireless voice and data services to consumer and business customers, along with broadband internet and fixed-line telephone services. Its main operations serve the American market, where it offers mobile plans, home internet and related communications services under the Verizon brand. The company also supplies connectivity and network services to enterprise and government customers.
Verizon Communications Inc. trades under the code 0Q1S on the London Stock Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Verizon Communications Inc. (0Q1S) trades on the London Stock Exchange in UK. It last closed at USD 43.25 on 28 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 2,073 of 3,789 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.9% and over the last three months it fell 10.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.8% | ||
| From 52-week high | -15.9% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.5% | ||
| 6-month return | -7.7% | ||
| 12-month return, skipping the last month | 20.5% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.1% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.03M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 35 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −7.1% |
| 3 months | −10.5% |
| 6 months | −7.7% |
| 1 year | +11.9% |
| 3 years | +48.6% |
| 5 years | +7.2% |
Signals
| 50-day / 200-day average | 47.77 / 46.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Jan 2026 | USD 0.6900 |
| 10 Oct 2025 | USD 0.6900 |
| 9 Jul 2025 | USD 0.6775 |
| 10 Apr 2025 | USD 0.6775 |
| 9 Jan 2025 | USD 0.6775 |
| 9 Oct 2024 | USD 0.6775 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.